Dove Barbanel
Lawyers
Associate in our Corporate practice, based in Northern California.
Experience
Recent Work
- CytomX Therapeutics $100 million stock offering
- McKesson $850 million acquisition of controlling interest in PRISM Vision
- Ionis Pharmaceuticals $500.3 million follow-on offering
- Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
- Siemens acquisition of Trayer Engineering
- CytomX Therapeutics $58.3 million at-the-market offering
- Revolution Medicines $500 million at-the-market offering
- SGH $175 million convertible notes offering and capped call transactions
- AssetMark strategic alliance with Morningstar and related acquisition of assets
- Bloom Energy $402.5 million green convertible notes offering
- Doma take-private acquisition by Title Resources Group
- Intel $2.55 billion senior notes offering
- UCT acquisition of HIS Innovations Group
- DexCom $1.25 billion convertible notes offering and capped call transactions
- Revolution Medicines $345 million follow-on offering
- Natera $400 million follow-on offering
Education
J.D., New York University School of Law
B.A., Political Science, University of Chicago
Qualifications and admissions
- State of California